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813 Video-assisted wedge resection and local radiotherapy for peripheral lung
cancer in high-risk patients: The Cancer and Leukemia Group B (CALGB)
9335, a phase II, multi-institutional cooperative group study
Hani Shennib, MD, Jeffrey Bogart, MD, James E. Herndon II, PhD, Leslie Kohman, MD,
Robert Keenan, MD, Mark Green, MD, and David Sugarbaker, MD, on behalf of The Cancer
and Leukemia Group B and The Eastern Cooperative Oncology Group, Montreal, Quebec,
Canada; Syracuse, NY; Durham, NC; Pittsburgh, Pa; Charleston, SC; and Boston, Mass
This multi-institutional feasibility study revealed a 27% technical failure rate associated with
intention to treat high-risk patients with clinical T1 non–small cell lung cancer by video-
assisted wedge resection and local radiotherapy. Alteration in staging from clinical T1 to
pathologic T2 or benign lesions was a contributing factor.
819 Large-cell neuroendocrine carcinoma of the lung: A clinicopathologic study
of eighteen cases and the efficacy of adjuvant treatment with octreotide
Pier Luigi Filosso, MD, Enrico Ruffini, MD, Alberto Oliaro, MD, Ottavio Rena, MD,
Caterina Casadio, MD, Maurizio Mancuso, MD, Davide Turello, MD,
Riccardo Carlo Cristofori, MD, and Giuliano Maggi, MD, Torino and Novara, Italy
Large cell neuroendocrine carcinomas of the lung are uncommon tumors with poor prognosis
and high recurrences rates, even in stage I or with radical resection. Optimal adjuvant therapy
has not been defined. Octreotide alone or in combination with radiotherapy seems to improve
long-term survival, reducing the risk of recurrence.
825 Border between N1 and N2 stations in lung carcinoma: Lessons from lymph
node metastatic patterns of lower lobe tumors
Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi Yuki, MD,
Takeshi Mimura, MD, Hiroyuki Nitanda, MD, Kei Miyoshi, MD, and
Noriaki Tsubota, MD, PhD, Akashi City, Japan
We examined lymph node metastases and survivals according to nodal involvement in 604
patients with completely resected lower lobe non–small cell lung carcinoma. Patients with
involvement up to interlobar nodes (station 11), up to main bronchus nodes (station 10), and up
to subcarinal nodes (station 7) had similar prognoses.
Evolving Technology
(ET)
831 Off-pump replacement of the pulmonary valve in large right ventricular
outflow tracts: A hybrid approach
Younes Boudjemline, MD, Silvia Schievano, MD, Caroline Bonnet, MD, Louise Coats, MD,
Gabriella Agnoletti, MD, Sachin Khambadkone, MD, Damien Bonnet, MD,
John Deanfield, MD, Daniel Sidi, MD, and Philipp Bonhoeffer, MD, Paris, France, and
London, United Kingdom
Percutaneous PVR has recently opened new perspectives into the replacement of cardiac valves,
although, in large RVOTs, it is technically impossible with the current device. We imagined a
hybrid approach in which cooperation between surgeons and cardiac interventionists would
permit a stepwise implantation without necessitating ECC. We report our experience of hybrid
PVR in ewes.
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